05/01/2025
4:00 PM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-C | |
04/30/2025
5:16 PM | Nunn Jason Raleigh (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
4:00 PM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-C | |
04/30/2025
7:27 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
7:30 AM | Regulus Therapeutics (Subject)
| Form SC14D9C | |
03/27/2025
6:15 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
4:00 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RGLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/30/2025
3:14 PM | Regulus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/15/2025
4:00 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
1:35 PM | DAFNA Capital Management LLC (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
3:26 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
3:02 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G | |
08/08/2024
3:24 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
3:18 PM | Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:23 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
3:20 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:21 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:21 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:16 PM | Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:33 PM | Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:54 PM | Regulus Therapeutics (Filer)
| Form 424B5 | |
